Search

Carl D Shelley

from Dennis Port, MA
Age ~79

Carl Shelley Phones & Addresses

  • 11 Franklin Rd, Dennis Port, MA 02639 (508) 694-6318
  • Dennisport, MA
  • 106 Riverside Dr, West Harwich, MA 02671
  • 20 Sunset Dr, South Easton, MA 02375 (508) 238-6097
  • Brockton, MA
  • 20 Sunset Dr, South Easton, MA 02375 (508) 769-4786

Work

Position: Production Occupations

Publications

Us Patents

Method For Treating Chronic Lymphoid Leukemia

View page
US Patent:
20080293661, Nov 27, 2008
Filed:
May 19, 2008
Appl. No.:
12/123078
Inventors:
Carl Simon SHELLEY - Charlestown MA, US
Sylvie GALIEGUE-ZOUITINA - Lille, FR
Assignee:
THE GENERAL HOSPITAL CORPORATION - Boston MA
International Classification:
A61K 31/711
C12Q 1/02
C12Q 1/68
C12Q 1/66
A61P 35/02
US Classification:
514 44, 435 29, 435 6, 435 8
Abstract:
Embodiments of the invention relates to the treatment of chronic lymphoid leukemia. The invention provides treatment, diagnostic, and drug discovery strategies for chronic lymphoid leukemia. Reconstitution of RhoH expression in vitro inhibits neoplastic proliferation and the process of trans-endothelial migration that underlies much of the pathology of CCL. RhoH reconstitution also limits malignant progression in vivo. Therefore, RhoH reconstitution represents a new therapeutic strategy in the fight against chronic lymphoid leukemia.

Methods For Diagnosing And Treating Tumors And Suppressing Cd Promoters

View page
US Patent:
20060216231, Sep 28, 2006
Filed:
Sep 23, 2003
Appl. No.:
10/528948
Inventors:
Carl Shelley - Charlestown MA, US
Omid Farokhzad - Chestnut Hill MA, US
International Classification:
A61K 51/00
A61K 48/00
A61K 39/395
C12Q 1/68
G01N 33/574
US Classification:
424001490, 435006000, 435007230, 424155100, 514044000
Abstract:
Methods of treating tumors, reducing white blood cell numbers, and inhibiting CD promoters are provided.

Identification Of Novel Diagnostics And Therapeutics By Modulating Rhoh

View page
US Patent:
20170074883, Mar 16, 2017
Filed:
Sep 14, 2016
Appl. No.:
15/265782
Inventors:
- Hull MA, US
Carl Simon Shelley - Hull MA, US
Assignee:
Leukemia Therapeutics, LLC - Hull MA
International Classification:
G01N 33/574
C12Q 1/68
Abstract:
The disclosure relates to identifying novel therapeutic targets and/or diagnostic and/or prognostic markers by correcting abnormal RhoH expression in a hematopoietic cell.
Carl D Shelley from Dennis Port, MA, age ~79 Get Report